CME

CME


Latest Episodes

What Are the Clinical Features of HER2 Amplified Colorectal Cancers?
March 20, 2023

Host: Andrea Cercek, MD This program explores treatment options for patients with human epidermal growth factor receptor 2 (HER2)-positive metastatic colorectal cancer (mCRC). To make informed decisions when treating patients with HER2-positive

Don’t Let Hyperkalemia Get You Down When Potassium Goes Up in Your Patients with Heart Failure
March 15, 2023

Host: Javed Butler, MD, MBA, MPH Guest: Ileana L. Pia, MD, MPH, FAHA, FACC Guest: Patrick Rossignol, MD, PhD In heart failure, there is a propensity to down-titrate or discontinue guideline-directed medical therapy in the presence of hy

Cervical Cancer Screening: The Case of the Young Patient
March 07, 2023

Host: Warner K. Huh, MD Guest: Leigh Anne Cantrell, MD, MSPH Explore the case of a young patient to see the ACS and ASCCP cervical cancer screening guidelines in action. Who needs to be screened, how is it best to screen, and what's the best

Molecular-Driven Treatment Advances in HER2+ Metastatic Colorectal Cancer
February 28, 2023

Host: Tanios S. Bekaii-Saab, MD Guest: Joleen M. Hubbard, MD Are you familiar with the most recent clinical data surrounding the treatment of HER2-positive metastatic colorectal cancer? Listen in as Drs. Tanios Bekii-Saab and Joleen Hubbard

Personalizing the Treatment of Recurrent/Metastatic HNSCC: A Multifactorial Path
February 28, 2023

Host: Barbara Burtness, MD Guest: Nabil F. Saba, MD, FACP KEYNOTE-048 has opened new vistas to managing patients with recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC). Nonetheless, uncertainties remain in matching the c

Parallels Between Kidney Transplantation and Maternal Anti-Fetal Rejection
February 28, 2023

Host: Lee P. Shulman, MD, FACMG, FACOG Guest: Alexandra Benachi, MD, PhD Guest: Julien Zuber, MD, PhD Program Chairman: Roberto Romero, MD, DMedSci Chief, Perinatology Research Branch Division of Maternal-Fetal Medicine and Obstetrics Di

Diabetic Eye Disease Pipeline Therapies Part 2: High-dose Aflibercept & Gene Therapy
February 21, 2023

Host: Christina Y. Weng, MD, MBA Guest: Glenn Yiu, MD, PhD This discussion with Program Chair Christina Y. Weng, MD, MBA, and Glenn Yiu, MD, PhD, includes a case study that highlights challenges with managing diabetic eye disease during the

Diabetic Eye Disease Pipeline Therapies Part 1: Faricimab, KSI-301, and OPT-302
February 21, 2023

Host: Christina Y. Weng, MD, MBA Guest: David Eichenbaum, MD This discussion with Program Chair Christina Y. Weng, MD, MBA, and David A Eichenbaum, MD, includes a case study that highlights challenges with managing diabetic eye disease durin

Diabetic Eye Disease Pipeline Therapies Part 3: Brolucizumab & PDS
February 21, 2023

Host: Christina Y. Weng, MD, MBA Guest: Sophie J. Bakri, MD This discussion with Program Chair Christina Y. Weng, MD, MBA, and Sophie J. Bakri, MD, includes a case study that highlights challenges with managing diabetic eye disease during th

Wet AMD Pipeline Therapies Part 3: KSI-301 and GB-102
February 21, 2023

Host: Christina Y. Weng, MD, MBA Guest: Basil K. Williams Jr, MD In this video case discussion, Program Chair Christina Y. Weng, MD, MBA, and Basil K. Williams Jr, MD, review details of a patient with wet age-related macular degeneration tre